Archive · 13 Sep 2025
India Licenses First Indigenous Malaria Vaccine, AdFalciVax
India is making progress in the fight against malaria!
Researchers created a new vaccine called AdFalciVax that can help stop the disease.
This vaccine targets two stages of the malaria parasite, which is a big step forward.
The government has licensed the vaccine to five companies to produce it.
Tests have shown it works well, and it can be stored at room temperature for a long time.
India has already reduced malaria cases and deaths significantly.
This vaccine is expected to help the country achieve its goal of eliminating malaria by 2030.
ICMR licensed the first multi-stage malaria vaccine, AdFalciVax, to five companies.
AdFalciVax targets two stages of the Plasmodium falciparum parasite.
The vaccine aims to prevent infection and reduce transmission of malaria.
Preclinical data shows the vaccine has advantages over existing vaccines.
India has significantly reduced malaria cases and deaths between 2015 and 2024.
- Who
- ICMR and five companies.
- What
- Licensed India's first indigenous multi-stage malaria vaccine.
- When
- Earlier this week.
- Where
- India.
- Why
- To eliminate malaria by 2030.
- Vaccine Name
- AdFalciVax
- Target
- Two stages of Plasmodium falciparum
- Developers
- ICMR and partners
- Licensed to
- 5 companies
- Purpose
- Prevent malaria infection and transmission
- Efficacy
- Demonstrated in preclinical stage
- Storage
- Effective for over nine months at room temperature